Format

Send to

Choose Destination
J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):1007-1009. doi: 10.1136/jnnp-2017-316689. Epub 2017 Oct 10.

High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy.

Author information

1
Department of Hematology, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
2
Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands.
3
University College London Hospitals NHS Foundation Trust, London, UK.
4
Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
5
Lymphoma and Myeloma Center (LYMMCARE), Amsterdam, The Netherlands.
6
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
7
Great Ormond Street Hospital, London, UK.
8
Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
9
Department of Hematology, UMC Utrecht Cancer Center, Amsterdam, The Netherlands.

KEYWORDS:

genetics; myelin; neurooncology; paraproteinaemia; peripheral neuropathology

PMID:
29018161
DOI:
10.1136/jnnp-2017-316689

Conflict of interest statement

Competing interests: MJK has consulted for or received compensation for presentations from Gilead, Celgene, Novartis, Roche, Millennium/Takeda, Kite Pharma and BMS, and has received research support from Celgene, Roche, Millennium and Sanofi. SD has received honoraria from Janssen. MPL has received honoraria from CSL Behring Grifols, UCB Pharma, Baxter and LfB. MCM has consulted for Jansen Cilag, Takeda, Amgen, BMS. The other authors had no disclosures to report.

Publication type

Publication type

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center